JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zimmer, L.
Right arrow Articles by Renaud, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zimmer, L.
Right arrow Articles by Renaud, B.
Journal of Nuclear Medicine Vol. 44 No. 9 1495-1501
© 2003 by Society of Nuclear Medicine


Basic Science Investigations

A Reduced Extracellular Serotonin Level Increases the 5-HT1A PET Ligand 18F-MPPF Binding in the Rat Hippocampus

Luc Zimmer, PharmD, PhD1,2, Latifa Rbah, MS1, Fabrice Giacomelli, MS3, Didier Le Bars, PharmD, PhD1 and Bernard Renaud, PhD2

1 Centre d’Exploration et de Recherche Médicales par Émission de Positons, Biomedical Cyclotron, Lyon, France
2 Institut National de la Santé et de la Recherche Médicale, Unité 512, Neurochimie et Neuropharmacologie, Lyon 1 University, Lyon, France
3 Cyclotron Research Center, Liège University, Liège, Belgium

4,2'-(Methoxyphenyl)-1-[2'-(N-2''-pyridinyl)-p-fluorobenzamido]ethylpiperazine (18F-MPPF) is a radiotracer used in clinical PET studies for the visualization of serotonin-1A (5-HT1A) receptors. In a previous study, we demonstrated that a rapid enhancement of extracellular serotonin concentrations influences 18F-MPPF-specific binding. Because endogenous serotonin is significantly decreased in some pathologies, the aim of this study was to determine whether 18F-MPPF is sensitive to depletion of this neurotransmitter. Methods: Using the ß-microprobe, an original ß+-sensitive intracerebral probe, and microdialysis, the effect of decreased serotonin on the specific binding of 18F-MPPF to 5-HT1A receptors was investigated in the hippocampus of the anesthetized rat. Extracellular serotonin was pharmacologically decreased in the hippocampus after a single injection of p-ethynylphenylalanine ([p-EPA] 5 mg/kg), a new tryptophan hydroxylase inhibitor. Results: Our results showed that the 18F-MPPF-specific binding was significantly enhanced after the decrease of extracellular serotonin. These results were confirmed by the 18F-MPPF distribution in cerebral tissues (hippocampus-to-cerebellum ratio) and by the decrease of the extracellular 18F-MPPF collected in hippocampal dialysates. Conclusion: This study further supports the view that 18F-MPPF binding potential is increased in the hippocampus if the endogenous serotonin is pharmacologically decreased after a p-EPA injection. This phenomenon will be an additional factor in the interpretation of the results from 18F-MPPF clinical PET studies.

Key Words: serotonin receptors • p-ethynylphenylalanine • 4,2'-(methoxyphenyl)-1-[2'-(N-2''-pyridinyl)-p-fluorobenzamido]-ethylpiperazine • serotonin • microdialysis • ß-microprobe




This article has been cited by other articles:


Home page
NeurologyHome page
L. Truchot, S. N. Costes, L. Zimmer, B. Laurent, D. Le Bars, C. Thomas-Anterion, B. Croisile, B. Mercier, M. Hermier, A. Vighetto, et al.
Up-regulation of hippocampal serotonin metabolism in mild cognitive impairment
Neurology, September 4, 2007; 69(10): 1012 - 1017.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2003 by the Society of Nuclear Medicine.